Eight million people living with HIV. Just over 6 million on treatment. Behind these big numbers lurk a universe of fascinating epidemiological dynamics. In this special briefing, Spotlight editor ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Amid the silence, stigma, and vulnerability surrounding the country’s rising HIV crisis, Filipino youth face growing risks.

FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month.

A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...

Therefore, innovative trial designs may be needed, such as the use of an external control group to measure the impact of HIV prevention products. The FDA provides combination product guidance, but the ...

A Houston physician has sued the federal government to cut benefits through the Affordable Care Act that requires access to pre-exposure prophylaxis (PrEP). The case, Kennedy v. Braidwood, is now ...

The PURPOSE trials illuminated the ways in which lenacapavir could be used as a means of pre-exposure prophylaxis effectively, but also featured several adverse events.

Harrison, who was 21 at the time, showed neither signs nor symptoms related to the virus, and was in a long-term relationship. Young and carefree, Harrison had rarely given her health a second thought ...

The funding for 2 million people to receive the twice-yearly preventative treatment lenacapavir is ‘receding in the chaos’ of ...

The shift toward universal screening for diseases like hepatitis C, hepatitis B, and HIV removes part of the burden of ...